Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., MCPS (Pulomonlogy), MRCGP (UK), F.C.P.S., MARH
Internal Medicine Specialist
M.B.B.S., MCPS (Pulomonlogy), MRCGP (UK), F.C.P.S., MARH
Gastroenterologist
MBBS, FCPS (Gasteronology)
Internal Medicine Specialist
MBBS, DTCD, FCPS (Medicine), MCPS
Endocrinologist
MBBS, FCPS (Medicine), FCPS (Endocrinology)
Internal Medicine Specialist
M.B.B.S , F.C.P.S. (Medicine)
Diabetologist
M.B.B.S., Diploma in Diabetology
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), M.R.C.P.S. ( . )
Internal Medicine Specialist
M.B.B.S, F.C.P.S. ( MEDICINE )
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures